News for hackers. Stuff that matters.
Re:Gene patents probably dead worldwide following Australian... by ihodes on Friday October 09, 2015 @11:22AM (#10360606)
An odd title; this patent was already struck down by the Supreme Court of the USA in 2013[0]. Now it's no longer valid in Australia. The cost of tests for BRCA1/2 mutations is dropping dramatically; were the medical apparatus of the USA not so drastically broken, the cost to consumers of this test would today cost the consumer around $50 US. This is thanks largely to the ACLU and some geneticists in NYC, including Harry Ostrer.

[0]: https://en.wikipedia.org/wiki/Myriad_Genetics#Association_fo...

Re:Gene patents probably dead worldwide following Australian... by matt_heimer on Friday October 09, 2015 @11:40AM (#10360762)
Does anyone know how the medical test at the heart of this legal issue compares to something like the raw data from 23andme? 23andme v4 gives you 25 SNPs for BRCA1 and BRCA2.
Re:Gene patents probably dead worldwide following Australian... by ihodes on Friday October 09, 2015 @12:04PM (#10360957)
A comprehensive test looking at the BRCAs may deeply sequence sequence the entire gene(s); spanning around 150 thousand base pairs. You'd not only want to look for SNPs, but novel SNVs, and various structural variants (SVs) and copy-number variants (CNVs). I don't know the most common class of mutations for BRCA1 and 2, so it may be the case that a smaller, cheaper panel could be nearly as effective as well.